Stevanato Group S.p.A.
STVN
NYSE·Healthcare·Medical - Instruments & Supplies·Mkt cap $5.7B
$20.59
▼ -0.70%
P/E
37.86
Mkt Cap
$5.7B
52-Wk Range
$12.89–$28.00
52-Week Range
$12.89 - $28.00
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 11.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
2 risks
- Low volatility (beta 0.7).
- Premium valuation to sector peers
Growth
Stable outlook
Value
Premium valuation to sector peers
Momentum
Strong
+11.9% over 3m
Quality
Stable
Strong fundamentals
Dividend
Token
0.30% yield
Smart-money signal
Who's buying STVN right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 4, 2026
Reported EPS of $0.16 vs $0.14 consensus (+10.5% surprise). Revenue of $344.9M vs $340.6M expected (+1.3%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+10.5%
Revenue trend · last 8Q
—
—
—
—
+9%
+4%
-9%
+8%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$324.5M
$386.1M
$299.7M
$327.0M
$354.0M
$400.9M
$273.6M
$352.7M
Margins · last 8Q
Profit
7.6%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: TD Cowen · Jun 16, 2026
vs Industry
How STVN stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.